Antiretroviral Therapy in HTLV-1 Infection: An Updated Overview

Antiretroviral Therapy in HTLV-1 Infection: An Updated Overview

The human T cell leukemic/lymphotropic virus type 1 (HTLV-1), discovered several years ago, is the causative agent for a rapid progressive haematological malignancy, adult T cell leukemia (ATL), for debilitating neurological diseases and for a number of inflammatory based diseases. Although the hete...

Full description

Bibliographic Details
Main Authors:	Francesca Marino-Merlo, Emanuela Balestrieri, Claudia Matteucci, Antonio Mastino, Sandro Grelli, Beatrice Macchi
Format:	Article
Language:	English
Published:	MDPI AG 2020-05-01
Series:	Pathogens
Subjects:	HTLV-1 antiretrovirals HAM/TSP ATL
Online Access:	https://www.mdpi.com/2076-0817/9/5/342

Similar Items

Planning and management to control and eliminate HTLV-1 infection in Iran
by: Reza Boostani, et al.
Published: (2021-03-01)

Editorial: HTLV-1: addressing unmet research needs, volume II
by: Marcela S. Cunha, et al.
Published: (2023-10-01)

HTLV-1 HBZ Viral Protein: A Key Player in HTLV-1 Mediated Diseases
by: Marco Baratella, et al.
Published: (2017-12-01)

Editorial: Molecular Pathology of HTLV-1
by: Umberto Bertazzoni, et al.
Published: (2018-12-01)

The Role of Chemokines in the Pathogenesis of HTLV-1
by: Razieh Zargari, et al.
Published: (2020-03-01)

Comparison of HTLV-I Proviral Load in Adult T Cell Leukemia/Lymphoma (ATL), HTLV-I-Associated Myelopathy (HAM-TSP) and Healthy Carriers
by: Mohammad Mehdi Akbarin, et al.
Published: (2013-03-01)

HTLV-1 Infection and Pathogenesis: New Insights from Cellular and Animal Models
by: Greta Forlani, et al.
Published: (2021-07-01)

The Road to HTLV-1-Induced Leukemia by Following the Subcellular Localization of HTLV-1-Encoded HBZ Protein
by: Roberto S. Accolla
Published: (2022-06-01)

Humoral immune response to HTLV-1 basic leucine zipper factor (HBZ) in HTLV-1-infected individuals
by: Enose-Akahata Yoshimi, et al.
Published: (2013-02-01)

Geographic distribution, clinical epidemiology and genetic diversity of the human oncogenic retrovirus HTLV-1 in Africa, the world’s largest endemic area
by: Antoine Gessain, et al.
Published: (2023-02-01)

AVALIAÇÃO DA MEDIDA DA INDEPENDÊNCIA FUNCIONAL EM PACIENTES COM HTLV EM CENTRO DE REFERÊNCIA
by: Nicholas Lourenço Malta, et al.
Published: (2023-10-01)

Prevalence of plasma autoantibody against cancer testis antigen NY-ESO-1 in HTLV-1 infected individuals with different clinical status
by: Yasuo Shiohama, et al.
Published: (2017-07-01)

Median Nerve Somatosensory Evoked Potential in HTLV-I Associated Myelopathy
by: Reza Boostani, et al.
Published: (2016-05-01)

Neurological aspects of HTLV-1 infection in Bahia: results from an 8-year cohort
by: Davi Tanajura
Published: (2015-01-01)

Impact of fractures and orthopedic surgeries in patients with HTLV-1 associated myelopathy/tropical spastic paraparesis
by: Pablo Julca-Copello, et al.
Published: (2020-09-01)

Adult T-cell leukemia-lymphoma in a patient with HTLV-I/II associated myelopathy Leucemia - linfoma de células T do adulto em um paciente com mielopatia associada a HTLV-I/II
by: Virgínia Freitas, et al.
Published: (1997-06-01)

Pulmonary involvement in patients with HTLV-I associated myelopathy Comprometimento pulmonar em pacientes com mielopatia associada ao HTLV-I
by: Kilma Mattos, et al.
Published: (1995-12-01)

Neurological Aspects of HIV-1/HTLV-1 and HIV-1/HTLV-2 Coinfection
by: Abelardo Q.-C. Araujo
Published: (2020-03-01)

Exacerbated inflammatory cellular immune response characteristics of HAM/TSP is observed in a large proportion of HTLV-I asymptomatic carriers
by: Gollob Kenneth J, et al.
Published: (2004-03-01)

The Relevance of HTLV-1-associated Myelopathy/Tropical Spastic Paraparesis in Iran: A Review Study
by: Masoud Keikha, et al.
Published: (2019-06-01)

Dichotomy in Fatal Outcomes in a Large Cohort of People Living with HTLV-1 in São Paulo, Brazil
by: Rosa Maria N. Marcusso, et al.
Published: (2019-12-01)

Overview on coinfection of HTLV-1 and tuberculosis: Mini-review
by: Masoud Keikha, et al.
Published: (2021-05-01)

Future Perspectives on Drug Targeting in Adult T Cell Leukemia-Lymphoma
by: Francesca Marino-Merlo, et al.
Published: (2018-05-01)

TNF-induced metalloproteinase-9 production is associated with neurological manifestations in HTLV-1-infected individuals
by: Mariele Guerra, et al.
Published: (2022-10-01)

The value of csf analysis for the differential diagnosis of HTLV-I associated myelopathy and multiple sclerosis Valor da análise do LCR para o diagnóstico diferencial de mielopatia associada ao HTLV-I e esclerose múltipla
by: Marzia Puccioni-Sohler, et al.
Published: (1995-12-01)

Systemic cytokines and GlycA discriminate disease status and predict corticosteroid response in HTLV-1-associated neuroinflammation
by: Tatiane Assone, et al.
Published: (2022-12-01)

HTLV-I associated myelopathy in the northern region of Brazil (Belém-Pará): serological and clinical features of three cases
by: Ricardo Ishak, et al.
Published: (2002-06-01)

Immunopathogenesis and neurological manifestations associated to HTLV-1 infection
by: Anselmo Souza, et al.
Published: (2012-10-01)

HTLV-1-associated myelopathy/tropical spastic paraplegia with sporadic late-onset nemaline myopathy: a case report
by: Eiji Matsuura, et al.
Published: (2023-05-01)

Comparison between the spastic paraplegia rating scale, Kurtzke scale, and Osame scale in the tropical spastic paraparesis/myelopathy associated with HTLV
by: Rodrigo Antonio Rocha da Cruz Adry, et al.
Published: (2012-06-01)

Minocycline modulates antigen-specific CTL activity through inactivation of mononuclear phagocytes in patients with HTLV-I associated neurologic disease
by: Enose-Akahata Yoshimi, et al.
Published: (2012-02-01)

The relationship between atopy and neurological manifestations in HTLV-1 infection
by: Raquel Crisóstomo Lima Verde, et al.

Role of HTLV-1 Tax and HBZ in the Pathogenesis of HAM/TSP
by: Yoshimi Enose-Akahata, et al.
Published: (2017-12-01)

Association Between HTLV-1 Genotypes and Risk of HAM/TSP
by: Mineki Saito
Published: (2019-05-01)

Lesões dermatológicas em pacientes infectados pelo vírus linfotrópico humano de células T do tipo 1 (HTLV-1) Dermatologic lesions in patients infected with the human T-cell lymphotropic vírus type 1 (HTLV-1)
by: Vandack Nobre, et al.
Published: (2005-02-01)

Mielopatias por HTLV-1 na cidade de Salvador, Bahia
by: Ailton Melo, et al.
Published: (1994-09-01)

Cytokine Networks Dysregulation during HTLV-1 Infection and Associated Diseases
by: Nicolas Futsch, et al.
Published: (2018-12-01)

Germinal epimutation of Fragile Histidine Triad (FHIT) gene is associated with progression to acute and chronic adult T-cell leukemia diseases
by: Marcia Bellon, et al.
Published: (2021-06-01)

Effects of host restriction factors and the HTLV-1 subtype on susceptibility to HTLV-1-associated myelopathy/tropical spastic paraparesis
by: Satoshi Nozuma, et al.
Published: (2017-04-01)

Human T-lymphotropic Virus Type I (HTLV-I) Proviral Load and Clinical Features in Iranian HAM/TSP Patients
by: Rosita Vakili, et al.
Published: (2013-03-01)